– An experienced entrepreneur, Kirsty is the former CEO of Oxford spin-out company Latent Logic, which was acquired by Waymo, the world’s leading autonomous driving company, in 2019.
Oxford, UK: April 18, 2024: Oxford Science Enterprise (OSE), an independent investment firm set up to create, fund and build innovative businesses through a unique partnership with the University of Oxford, today announced that Kirsty Lloyd Jewkes announced the appointment of Entrepreneur-in-Residence (EIR) with a focus on creation. of deep tech companies.
Kirsty has over 10 years’ experience in entrepreneurship across deep technology and consumer sectors, with expertise in business development and expansion, operations and financing. Kirsty was CEO of Latent Logic, a spin-out from Oxford University’s School of Computer Science that employs cutting-edge deep learning to accelerate the development and scale-out of self-driving car technology. Latent Logic was acquired in 2019 by Waymo, a subsidiary of Alphabet, the world’s leading self-driving technology company.
Kirsty is a mentor at the Creative Destruction Lab, a seed-stage incubator for scalable science and technology-based companies, and part-time director of the Institute of Directors, a business organization set up to support entrepreneurship in the UK. He was also a director.
Sam Harman, acting head of deep tech, said: “Kirsty brings exceptional leadership and leadership qualities, combined with a deep understanding of both deep technology and the investor landscape. We continue to discover and build the next generation of innovative technology companies. We look forward to hearing her insight and expertise.”
Kirsty Lloyd-Jewkes added: “I am delighted to be joining Oxford Science Enterprise as Entrepreneur in Residence and am looking forward to immersing myself in the ground-breaking scientific and technological innovations underway at the University of Oxford. I’m excited to work with OSE’s deep tech team, which has a strong track record of creating and growing innovative companies that address:
OSE’s EIR program brings experienced entrepreneurs into the company to accelerate our mission to discover Oxford’s most promising scientific and technological innovations and build them into world-leading businesses. The program has resulted in innovative Oxford spin-out companies including neurology care platform Neu Health, photonic chip company Salience Labs and neuromodulation company Amber Therapeutics.
OSE’s Deep Tech team is actively investing to address some of humanity’s most pressing challenges. From artificial intelligence and quantum computing to next-generation herbicides, OSE is dedicated to helping visionary entrepreneurs build industry-changing businesses and become the next generation of global leaders. I am.
end
About Oxford Science Enterprise
Oxford Science Enterprise (OSE) is an independent 1 billion research company founded in 2015 to create, fund and build innovative businesses through a unique partnership with the world’s number one research university, the University of Oxford. A pound investment company.
This partnership will enable OSE to collaborate with some of the brightest scholars tackling the world’s toughest challenges. OSE works with a global network of entrepreneurs and advisors to go far beyond funding to bring these complex ideas to life and drive business success.
With an aggressive focus on its core portfolio of approximately 40 companies across three high-growth sectors: life sciences, health tech and deep tech, the company recognizes the path forward from breakthrough businesses and is flexible and long-term. We take a strong investment approach. Research for global markets takes time and resilience.
To date, OSE has invested £700m in over 80 ambitious companies built on Oxford science. A key figure in Oxford’s entrepreneurial ecosystem, OSE is highly motivated to foster an environment that fosters pioneering research and leads to commercial success.
Learn more: oxfordscienceenterprise.com | twitter | linkedin
contact address:
oxford science enterprise
Claire Larocca – media@oxfordsciences.com
Media inquiries:
Mark Swallow, Sandy Greenwood, Fraser Hall – MEDiSTRAVA Consulting
oxfordsciences@medistrava.com
+44 (0)203 928 6900
